Skip to main content
HR 6231 116th Congress House

Ensuring Access to COVID-19 Preventive Care Act of 2020

Official title: To ensure affordable coverage of certain vaccines and testing services under group health plans and group and individual health insurance coverage during the COVID-19 public health emergency.

Introduced: March 12, 2020 See on congress.gov
Health Advisory bodiesCardiovascular and respiratory healthEmergency medical services and trauma careHealth care costs and insurance
More subjectsShow fewer subjects
Health care coverage and accessHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methods
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 12, 2020
Referred to the House Committee on Energy and Commerce.
Mar 12, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 12, 2020

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Ensuring Access to COVID-19 Preventive Care Act of 2020

This bill requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020.

The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Schakowsky, Janice D.
Illinois · Mar 12, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6231/
MLA
"H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6231/.
Bluebook (legal)
H.R. 6231, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6231/.
Markdown link
[H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020](https://openamerica.io/bill/116-HR-6231/)
Report a problem